{
    "nctId": "NCT05300412",
    "briefTitle": "The Role of Interleukin-7 Serum Level as Biological Marker in Breast Cancer",
    "officialTitle": "The Role of Interleukin-7 Serum Level as Biological Marker in Breast Cancer: a Cross-sectional, Observational, and Analytical Study",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer Invasive",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 275,
    "primaryOutcomeMeasure": "Interleukin-7",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients with invasive breast cancer, confirmed with biopsy\n* Operable and without distant metastases.\n\nExclusion Criteria:\n\n* Patients with acute and/or chronic inflammatory diseases, rheumatoid disease and other malignancies occurring simultaneously\n* Patients receiving immune modulatory therapy\n* Patients previously treated by surgery, chemotherapy, radiotherapy, target therapy or endocrine therapy\n* Patients with dementia or any other psychological disorders unable to willingly participate in the study.\n\nExclusion Criteria for the control group:\n\n* Breast tumors or any other confirmed malignancies\n* Any acute or chronic inflammatory disease\n* Receiving immune modulatory therapy",
    "sex": "FEMALE",
    "minimumAge": "20 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}